Etiology of congenital agammaglobulinemia: Growth defect of precursor B lymphoblastoid cell lines and immunoglobulin gene rearrangements.
先天性无丙种球蛋白血症的病因:前体 B 淋巴母细胞系的生长缺陷和免疫球蛋白基因重排。
基本信息
- 批准号:62480224
- 负责人:
- 金额:$ 3.97万
- 依托单位:
- 依托单位国家:日本
- 项目类别:Grant-in-Aid for General Scientific Research (B)
- 财政年份:1987
- 资助国家:日本
- 起止时间:1987 至 1988
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
Epstein-Barr virus (EBV) induced B lymphoblastoid cell lines (B-LCL) were established from bone marrow cells of the patients with congenital agammaglobulinemia (CAG).We found several immature B-LCL, some of which possess no cell-surface and cytoplastic immunoglobulins, or possess only cytoplasmic heavy chains. We examined the mode of expression of B-cell associated antigens on EBV-induced B-LCL and failed to detect any CAG specific and developmental stage-specific expression of known B-cell related antigens on those B-LCL. These facts indicate that expression of B cell associated antigens on EBV-induced B-LCL does not depend on the developmental stage of B cells, rather depend on the state of EBV infections.If we can detect LCL which express immunoglobulins with very unusual manner, those LCL will probably give us oppotunities to elucidate the etiology of CAG. Fortunately we found 2 such cell lines, K5 and K4, from the same CAG patient. K5 was very unique because they expressed only IgD (delea,lambda) on the surface and produced IgD. K4 was also very unique because they produced lambda heavy chain, and both kappa and lambda light chains. Cell cloning experiments repeated 3 times definitely confirmed that K4 cells produced both kappa and lambda light chains with single mu chains. The pattern of immunoglobolin production seen on K4 and K5 was probably the first ones in the literature. We are going to clone immunoglobuline genes of K4 and K5, and to elucidate the genetic mechanism of the expression of unusual immunoglobulins.
用eb病毒(EBV)诱导的先天性无球蛋白血症(CAG)患者骨髓细胞建立B淋巴母细胞样细胞株(B- lcl)。我们发现了几种未成熟的B-LCL,其中一些不具有细胞表面和细胞质免疫球蛋白,或仅具有细胞质重链。我们检测了b细胞相关抗原在ebv诱导的B-LCL中的表达模式,但未能检测到任何CAG特异性和发育阶段特异性的已知b细胞相关抗原在这些B-LCL中的表达。这些事实表明,在EBV诱导的B- lcl中,B细胞相关抗原的表达并不取决于B细胞的发育阶段,而是取决于EBV感染的状态。如果我们能检测到表达免疫球蛋白方式异常的小细胞淋巴瘤,这些小细胞淋巴瘤可能会为我们阐明CAG的病因提供机会。幸运的是,我们从同一CAG患者身上发现了2个这样的细胞系,K5和K4。K5非常独特,因为它们只在表面表达IgD (delea,lambda)并产生IgD。K4也非常独特,因为它们产生了重链,以及轻链和重链。重复3次的细胞克隆实验明确地证实了K4细胞产生kappa和lambda轻链,且有单个mu链。在K4和K5上观察到的免疫球蛋白生成模式可能是文献中最早发现的。我们将克隆免疫球蛋白基因K4和K5,并阐明异常免疫球蛋白表达的遗传机制。
项目成果
期刊论文数量(20)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Minegishi N. et al.: "Chronic granulomatous disease with neutrophil membrane cytochrome b deficiency : demonstration by immunochemical staining with monoclonal antibody" Tohoku J. exp. Med. 154:143-148, 1988.
Minegishi N.等人:“伴有中性粒细胞膜细胞色素b缺乏的慢性肉芽肿病:通过单克隆抗体免疫化学染色进行证实”Tohoku J.exp。
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
Minegishi,M.,et al.: Leukemia Research. 12. 227-232 (1988)
Minegishi,M.,et al.:白血病研究。
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
Minegish,N.,et al.: Tohoku J.exp.Med.154. 143-148 (1988)
Minegish,N. 等人:Tohoku J.exp.Med.154。
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
Minegishi,N;et al: Tohoku J.exp.Med.154. 143-148 (1988)
Minegishi,N;等人:Tohoku J.exp.Med.154。
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
Kojima, H. et al.: "Predefined gene transfer for expression of a glycosphingolipid antigen by transfection with a cosmid genomic library prepared from a cell line in which the specific glyco-sphingolipid is highly expressed." BBRC. 143. 716-722 (1987)
Kojima, H. 等人:“通过用从特定鞘糖脂高度表达的细胞系制备的粘粒基因组文库转染来表达鞘糖脂抗原的预定义基因转移。”
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
TSUCHIYA Shigeru其他文献
TSUCHIYA Shigeru的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('TSUCHIYA Shigeru', 18)}}的其他基金
Homologous recombination-mediated gene correction in iPS cells o Ornithine transcarbamylase deficiency
iPS 细胞中同源重组介导的基因校正 o 鸟氨酸转氨甲酰酶缺陷
- 批准号:
23659511 - 财政年份:2011
- 资助金额:
$ 3.97万 - 项目类别:
Grant-in-Aid for Challenging Exploratory Research
Leukemogenesis due to insertional mutagenesis-a NOG mouse model-
插入突变引起的白血病发生-NOG小鼠模型-
- 批准号:
19390280 - 财政年份:2007
- 资助金额:
$ 3.97万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
Induction of human cytotoxic T cells by peptide-pulsed universal antigen presenting cells
肽脉冲通用抗原呈递细胞诱导人细胞毒性 T 细胞
- 批准号:
16390294 - 财政年份:2004
- 资助金额:
$ 3.97万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
GENE THERAPY FOR X-LINKED SEVERE COMBINED IMMUNODEFICIENCY DISEASE
X连锁严重联合免疫缺陷病的基因治疗
- 批准号:
14370240 - 财政年份:2002
- 资助金额:
$ 3.97万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
MECHANISM OF INFECTION OF EPSTEIN-BARR VIRUS TO T AND NK CELLS
EB病毒感染T细胞和NK细胞的机制
- 批准号:
12470165 - 财政年份:2000
- 资助金额:
$ 3.97万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
TARGET CELL SPECIFIC GENE TRANSFER BY ANTIFECTION AND REGULATION OF PROLIFERATION OF CANCER CELLS
通过抑制和调节癌细胞增殖进行靶细胞特异性基因转移
- 批准号:
10470173 - 财政年份:1998
- 资助金额:
$ 3.97万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
Function of the gene of Wiskott-Aldrich syndrome
Wiskott-Aldrich 综合征基因的功能
- 批准号:
08457219 - 财政年份:1996
- 资助金额:
$ 3.97万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
PURIFICATION OF HEMATOPOIETIC STEM CELLS BY A CD117 MONOCLONAL ANTIBODY,MTK1, IN ORDER TO TRANSFECT HUMAN GENES-A PRELIMINARY STUDY
CD117单克隆抗体MTK1纯化造血干细胞转染人类基因的初步研究
- 批准号:
06454295 - 财政年份:1994
- 资助金额:
$ 3.97万 - 项目类别:
Grant-in-Aid for General Scientific Research (B)
ESTABLISHMENT AND CHARACTERIZATION OF AN IMMATURE MYELOID CELL LINE, M-MOK, GROWN IN THE PRESENCE OF FIBROBLAST-FEEDER CELLS
在成纤维细胞饲养细胞存在下生长的未成熟骨髓细胞系 M-MOK 的建立和表征
- 批准号:
03454260 - 财政年份:1991
- 资助金额:
$ 3.97万 - 项目类别:
Grant-in-Aid for General Scientific Research (B)